Company Quick10K Filing
Windtree Therapeutics
10-Q 2020-03-31 Filed 2020-05-13
S-1 2020-01-27 Public Filing
S-1 2020-01-21 Public Filing
10-K 2019-12-31 Filed 2020-04-03
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-04-30 Public Filing
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-29
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-16
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-17
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-10
8-K 2020-05-06 Enter Agreement, Regulation FD, Exhibits
8-K 2020-04-30 Other Events
8-K 2020-04-24 Enter Agreement, Sale of Shares, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2020-04-20 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-04-02
8-K 2020-03-18 Enter Agreement, Off-BS Arrangement
8-K 2020-03-09 Officers
8-K 2020-01-21 Earnings
8-K 2019-12-11 Regulation FD, Other Events, Exhibits
8-K 2019-12-09 Enter Agreement, Sale of Shares, Regulation FD, Exhibits
8-K 2019-10-28 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-10-25 Earnings, Regulation FD, Other Events, Exhibits
8-K 2019-08-14 Other Events, Exhibits
8-K 2019-05-30 Other Events, Exhibits
8-K 2019-04-24 Officers, Other Events, Exhibits
8-K 2019-03-19 Officers
8-K 2019-01-31 Officers
8-K 2019-01-03 Regulation FD, Exhibits
8-K 2018-12-31 Officers, Exhibits
8-K 2018-12-21 Enter Agreement, M&A, Sale of Shares, Control, Officers, Other Events, Exhibits
8-K 2018-12-14 Officers, Exhibits
8-K 2018-12-07 Enter Agreement, Exhibits
8-K 2018-12-06 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-11-16 Enter Agreement, Off-BS Arrangement, Officers, Exhibits
8-K 2018-11-08 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-10-25 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-10-16 Enter Agreement, Exhibits
8-K 2018-10-03 Enter Agreement, M&A, Officers, Exhibits
8-K 2018-09-13 Enter Agreement, Exhibits
8-K 2018-08-29 Enter Agreement, Exhibits
8-K 2018-08-27 Other Events, Exhibits
8-K 2018-08-20 Enter Agreement, Exhibits
8-K 2018-08-16
8-K 2018-07-24 Other Events, Exhibits
8-K 2018-07-06 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-06-19 Enter Agreement, Exhibits
8-K 2018-03-30 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-03-16 Exhibits
8-K 2018-03-05 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-03-01 Enter Agreement, Exhibits
8-K 2018-02-27 Other Events, Exhibits
8-K 2018-01-30 Other Events, Exhibits
8-K 2018-01-10 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-01-08 Regulation FD, Exhibits

Windtree Therapeutics Financials

WINT Metrics, Comps, Filings

Quarterly | Annual

Business

Windtree Therapeutics, Inc. (referred to as “we,” “us,” or the “Company”) is a Delaware corporation, with our principal offices located at 2600 Kelly Road, Suite 100, Warrington, Pennsylvania. We were incorporated as a Delaware corporation in 1992. Our telephone number is 215-488-9300 and our corporate website address is www.windtreetx.com. Our common stock is currently traded on The OTCQB® Venture Market (OTCQB) quotation system operated by The OTC Markets Group Inc., and our symbol is WINT.

We are a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute pulmonary and cardiovascular diseases. Historically, our focus has been on the development of our proprietary KL4 surfactant technology and aerosol delivery system (ADS) technology for the treatment and or prevention of respiratory distress syndrome (RDS) in premature infants. Following our merger with CVie Investments in December 2018 (discussed below), we are also focusing on therapies for acute heart failure and hypertension and associated organ dysfunction.

Our four lead development programs are (1) istaroxime for treatment of acute decompensated heart failure (ADHF), (2) AEROSURF® (lucinactant for inhalation) for non-invasive delivery of our lyophilized KL4 surfactant to treat RDS in premature infants, (3) lyophilized KL4 surfactant intratracheal suspension for RDS, and (4) rostafuroxin for genetically associated hypertension.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Metaurus Equity Component Trust (XDIV) 147,784 45.7 13% 24,806 357 0 0 3,222 3,222 147,314
Alliance One (AOI) 146,761 15% 12.1 -5% 1,978,868 1,867,233 1,775,380 260,147 -93,296 120,113 1,452,845
First Keystone (FKYS) 146,539 10.8 1% 1,019,994 892,054 0 0 7,696 17,168 185,789
Cytodyn (CYDY) 171,286 -3.5 -269% 20,874 29,788 0 0 -56,187 -48,802 172,474
Northwest Biotherapeutics (NWBO) 145,700 0% -6.4 -266% 10,145 64,680 1,513 0 -26,969 -24,686 157,385
Kentucky Bancshares (KTYB) 142,320 6.7 1% 1,083,015 965,839 0 0 9,664 17,429 117,030
Windtree Therapeutics (WINT) 138,735 0% -5.8 -24% 100,632 47,561 427 0 -24,027 -22,988 134,144
SolarWindow Technologies (WNDW) 158,348 -31.5 -25% 19,230 260 0 0 -4,722 -4,462 140,358
Mohawk Group (MWK) 136,195 41% -7.6 -26% 72,828 53,320 70,971 29,287 -18,942 -16,635 127,073
First Northern Community Bancorp (FNRN) 136,114 0.0 1% 1,287,263 1,157,741 0 0 11,145 16,699 21
JRSIS Health Care (JRSS) 135,419 0% 23.1 5% 53,817 29,543 22,907 0 2,913 5,783 133,410
magicJack VocalTec (CALL) 135,362 64% 5.6 5% 144,276 95,065 80,267 51,525 6,495 13,150 73,254
Federal Street Acquisition (FSAC) 135,270 -26.8 -1% 471,272 25,787 0 0 -3,966 -4,930 132,081
Invesco DB Precious Metals Fund (DBP) 133,440 10.1 10% 133,936 3,438 0 0 13,252 13,252 133,440
Bright Mountain Media (BMTM) 132,589 27% -40.9 -12% 28,364 7,229 3,915 1,041 -3,451 -3,224 132,001
Living 3D (LTDH) 131,496 -27% -587.9 -294% 80 957 36 -10 -236 -224 131,491
Darkpulse (KLMK) 130,846 -596.4 -114% 576 3,218 0 0 -659 -221 131,978
Invesco CurrencyShares Canadian Dollar Trust (FXC) 129,195 0% -23.9 1% 115,580 40 1,541 0 993 993 -23,705
Gastar Exploration (GST) 129,171 0% -45.1 -24% 335,253 447,533 82,913 0 -81,839 -10,744 484,737
Contango Ore (CTGO) 128,732 -16.5 -96% 7,639 407 0 0 -7,322 -7,322 121,121

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash21,54215,41110,18954,80246,00836,06426,89226,37031,25321,17786,28375,94265,55754,91544,71135,58326,09146,30838,72229,40020,33012,3835,5888,2472,7531,9772,0401,9947787802,2246,2774,591
Accounts Receivable67041220
Inventory105128195036117112173443429270000
PP&E2,8392,5852,2932,1432,2351,99511,3021,6601,4931,41711,9102,0072,1781,77212,6891,6651,2451,1869,5051,1001,0481,0228,0141,0189779308,038844804764826893877
Assets25,24818,72313,32457,73849,18139,75229,94329,16233,90723,63189,31779,49869,47458,30947,49938,12228,20052,73244,37734,71024,99816,4349,69911,7075,8254,6573,3472,9671,9791,943111,626105,245100,632
Accounts Payable1,9861,3861,1111,3391,3352081,1661,8251,9191,4891,4332,5781,5071,4033507022,3142,4573,2635,5127,7135,2371,8132,3122,8463,7703,0484,6834,2584,5191,417724607
Long-Term Debt26024222420518616721710,00010,00010,00030,00030,00030,00030,00030,00021,30021,40025,00025,00025,00025,00025,00025,00025,00025,00025,0000
Liabilities16,04113,99512,06015,50513,48016,70112,29019,70517,09118,15630,81630,69130,26829,34428,30030,31031,27834,84236,11139,68740,21739,28438,52937,46738,00842,10527,26731,03330,36333,27648,63046,97547,561
Stockholders' Equity9,2074,7281,26442,23335,70123,05117,6539,45716,8165,47558,50148,80739,20628,96519,1997,812-3,07817,8908,266-4,977-15,219-22,850-28,830-25,760-32,183-37,448-23,920-28,066-28,384-31,33362,99658,27053,071
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Revenue311,0935271,1841917566655751069619001022041,051229401580
Cost of Revenue
Gross Profit
R&D4,6153,9814,0144,5335,2065,7436,0888,4726,8636,5745,7525,5906,8586,4717,7717,0827,1296,4528,22510,3608,3167,0815,9486,4135,4833,0622,4183,1182,8792,1973,3423,4133,792
SG&A1,9662,1891,8892,0473,6104,2556,5324,2204,1294,2994,0704,4234,4464,1263,7373,3533,3832,0572,2113,6571,7831,6131,3201,9221,8041,7491,1821,9261,2081,5003,3553,2403,395
Tax
Net Income-8,076-4,751-4,301-10,016-7,138-13,346-6,815-12,635-8,627-12,223-11,729-11,476-10,623-11,324-10,635-12,179-11,326-21,556-10,109-13,901-10,624-8,363-6,602-8,724-6,752-5,4432,473-4,512-2,121-3,927-6,537-6,437-7,126
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash Operating-6,032-5,524-5,546-8,424-9,851-9,063-10,235-10,208-9,977-10,034-10,279-9,979-10,829-8,660-9,676-7,522-7,646-9,185-9,127-8,332-33,589-7,332-5,529-4,808-2,546-3,766-3,278-8,759-6,621-3,824
Cash Investing-62-18-138-380-75-43-1200-84-404-497-386204-448205-560-137-12-17-254-20-4009042510,8372,597
Cash Financing-3732050,29710-18-669,83315,091-1575,544435-20-17-20-2127,74400694027099,786394,8712,5002,5423,279-598-27-346